An Emergency Contraceptive Option for Cats During COVID-19 Delayed Surgery

by Kristen

When:
April 10, 2020 @ 2:00 pm – 3:00 pm
2020-04-10T14:00:00-05:00
2020-04-10T15:00:00-05:00
Where:
Online Webinar - Maddie's Fund
Cost:
Free
Contact:
Maddie's Fund

Veterinarians and animal welfare organizations are invited to join veterinary experts for a free webinar about new possibilities with non-surgical contraception solutions for cats.

As many communities defer sterilization surgeries for dogs and cats, the Alliance for Contraception in Cats & Dogs (ACC&D) believes megestrol acetate (MA) is an option for short-term contraception of some female cats. The risk/benefit change and short-term nature of COVID-19 has prompted their recommendation.

Find out more about how this could work in practice. Presenters will be augmented by a veterinary specialist in small animal reproduction and a specialist in regulatory approval for animal health. There will be time for Q&A. Materials will cover and build on a statement you can read at www.acc-d.org.

The webcast will be available to view on-demand 24 hours after it ends.

Presenters:
Joyce Briggs, MS, President, Alliance for Contraception in Cats & Dogs (ACC&D)

Michael Greenberg, DVM, Director of Outreach Programs, Maddies’ Fund

Julie K. Levy, DVM, PhD, DACVIM, DABVP, Professor of Shelter Medicine Education, University of Florida

Panelists:
Michelle Kutzler, DVM, PhD, DACT, Associate Professor, Oregon State University – Dr. Kutzler has worked in the field of veterinary reproduction since 1993 in both private and academic clinical practice and research. She has written over 70 peer reviewed articles, over 120 scientific abstracts, over 40 book chapters and 1 book. She has been investigating non-surgical methods for contraception for the past 12 years and is on ACC&D’s Scientific Advisory Board.

Linda Rhodes VMD, PhD – Dr. Rhodes specializes in bringing new animal drugs to market in the U.S. She has worked to bring the contraceptive implant for dogs, Suprelorin®, through regulatory approval in the EU.. Her PhD is in reproductive endocrinology. She is well-versed in the extra-label use of compounded formulations. Dr. Rhodes serves on the Board of ACC&D.